Legalization of Cannabis Does Not Reduce Opioid Prescribing in Patients With Inflammatory Bowel Disease: A Difference-in-Difference Analysis.

Mohamed NoureldinTony VanShirley Cohen-Mekelburg Frank I ScottPeter D R HigginsRyan W StidhamJason K Hou Akbar K Waljee Jeffrey A Berinstein

Published in: The American journal of gastroenterology (2024)

Opioid prescribing decreased from 2009 to 2016 among patients with IBD in both states with legalized and state without legalized cannabis, similar to what has been observed nationally across a variety of diseases. Cannabis legalization was not associated with a lower rate of opioid prescribing for patients with IBD.

Keyphrases

primary care
chronic pain
pain management
patients with inflammatory bowel disease
adverse drug
ulcerative colitis